• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于新型D指数的强大列线图预测肝细胞癌手术切除后的预后

A Powerful Nomogram Based on the Novel D-Index to Predict Prognosis After Surgical Resection of Hepatocellular Carcinoma.

作者信息

Du Xia, Guo Cheng-Nan, Bao Xiao-Dong

机构信息

Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.

Department of Statistics, School of Public Health and Management, Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.

出版信息

Cancer Manag Res. 2021 Mar 17;13:2581-2594. doi: 10.2147/CMAR.S305253. eCollection 2021.

DOI:10.2147/CMAR.S305253
PMID:33762849
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7982552/
Abstract

PURPOSE

Conventional staging and scoring systems such as the Tumor, Node, and Metastasis; Cancer of the Liver Italian Program; Barcelona Clinic Liver Cancer; and Okuda have failed to predict overall survival (OS) in patients with resected primary hepatocellular carcinoma. Thus, we aimed to establish a novel D-index and nomogram to improve prognostic accuracy.

PATIENTS AND METHODS

We selected 396 patients who underwent liver resection between January 2007 and February 2015 at the First Affiliated Hospital of Wenzhou Medical University. These patients were randomly divided into the training and validation groups in a ratio of 7:3.

RESULTS

We generated a nomogram using five independent risk factors, including the D-index (calculated by total bilirubin × tumor size/the ratio of fat-to-muscle area ) in the training set. The predictive performance of the nomogram was similar in both the training and validation cohorts according to the concordance index. The nomogram demonstrated the strongest predictive power for 1-year, 3-year, and 5-year OS, with the area under the receiving operating characteristic curve being 0.8486, 0.7785, and 0.752, respectively. The calibration curves exhibited stable capabilities in both cohorts. The stratification of the Kaplan-Meier curve was significant (P < 0.001).

CONCLUSION

The associated nomogram of the D-index demonstrated a powerful and accurate predictive ability for OS in patients with primary hepatocellular carcinoma.

摘要

目的

传统的分期和评分系统,如肿瘤、淋巴结和转移(TNM)分期、意大利肝癌计划(CLIP)、巴塞罗那临床肝癌(BCLC)分期和奥田分期,均无法预测接受手术切除的原发性肝细胞癌患者的总生存期(OS)。因此,我们旨在建立一种新的D指数和列线图,以提高预后准确性。

患者与方法

我们选取了2007年1月至2015年2月在温州医科大学附属第一医院接受肝切除术的396例患者。这些患者按7:3的比例随机分为训练组和验证组。

结果

我们在训练集中使用五个独立危险因素生成了列线图,其中包括D指数(通过总胆红素×肿瘤大小/脂肪与肌肉面积之比计算得出)。根据一致性指数,列线图在训练队列和验证队列中的预测性能相似。列线图对1年、3年和5年总生存期的预测能力最强,受试者工作特征曲线下面积分别为0.8486、0.7785和0.752。校准曲线在两个队列中均表现出稳定的性能。Kaplan-Meier曲线分层具有显著性(P<0.001)。

结论

D指数相关列线图对原发性肝细胞癌患者的总生存期具有强大且准确的预测能力。

相似文献

1
A Powerful Nomogram Based on the Novel D-Index to Predict Prognosis After Surgical Resection of Hepatocellular Carcinoma.基于新型D指数的强大列线图预测肝细胞癌手术切除后的预后
Cancer Manag Res. 2021 Mar 17;13:2581-2594. doi: 10.2147/CMAR.S305253. eCollection 2021.
2
Use of a novel index, the A-index, and its associated nomogram to predict overall survival rates after resection of primary hepatocellular carcinoma.使用一种新的指数,即 A 指数及其相关的列线图,来预测原发性肝细胞癌切除术后的总生存率。
Clin Chim Acta. 2020 Jan;500:34-41. doi: 10.1016/j.cca.2019.10.001. Epub 2019 Oct 23.
3
A nomogram integrating hepatic reserve and tumor characteristics for hepatocellular carcinoma following curative liver resection.基于肝脏储备功能和肿瘤特征的肝癌根治性切除术后列线图模型。
Clin Chim Acta. 2018 Oct;485:187-194. doi: 10.1016/j.cca.2018.06.020. Epub 2018 Jun 15.
4
Nomogram prediction of individual prognosis of patients with hepatocellular carcinoma.肝细胞癌患者个体预后的列线图预测
BMC Cancer. 2017 Jan 31;17(1):91. doi: 10.1186/s12885-017-3062-6.
5
Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma.肉瘤样肝细胞癌列线图预后评估模型的建立与验证。
Adv Ther. 2020 Jul;37(7):3185-3205. doi: 10.1007/s12325-020-01357-3. Epub 2020 May 20.
6
Development and validation of a prognostic nomogram for colorectal cancer after surgery.一种用于结直肠癌术后的预后列线图的开发与验证
World J Clin Cases. 2021 Jul 26;9(21):5860-5872. doi: 10.12998/wjcc.v9.i21.5860.
7
A sample model established by S-index predicting overall survival after curative resection of primary hepatocellular carcinoma.通过S指数建立的预测原发性肝细胞癌根治性切除术后总生存期的样本模型。
Cancer Manag Res. 2019 Jan 14;11:693-703. doi: 10.2147/CMAR.S193593. eCollection 2019.
8
A nomogram prognostic model for early hepatocellular carcinoma with diabetes mellitus after primary liver resection based on the admission characteristics.基于入院特征的原发性肝切除术后合并糖尿病的早期肝细胞癌列线图预后模型
Front Pharmacol. 2024 Feb 15;15:1360478. doi: 10.3389/fphar.2024.1360478. eCollection 2024.
9
Predictive potential of Nomogram based on GMWG for patients with hepatocellular carcinoma after radical resection.基于 GMWG 的列线图对肝癌根治性切除术后患者的预测潜能。
BMC Cancer. 2021 Jul 15;21(1):817. doi: 10.1186/s12885-021-08565-2.
10
Establishment of a Nomogram by Integrating Molecular Markers and Tumor-Node-Metastasis Staging System for Predicting the Prognosis of Hepatocellular Carcinoma.建立一个列线图,通过整合分子标志物和肿瘤-淋巴结-转移分期系统来预测肝细胞癌的预后。
Dig Surg. 2019;36(5):426-432. doi: 10.1159/000494219. Epub 2018 Nov 27.

引用本文的文献

1
Development and validation of a nomogram for survival prediction in hepatocellular carcinoma after partial hepatectomy.开发并验证肝癌部分肝切除术后生存预测的列线图。
BMC Surg. 2023 Jan 30;23(1):27. doi: 10.1186/s12893-023-01922-x.
2
Development and Validation of a Risk Nomogram Model for Perioperative Respiratory Adverse Events in Children Undergoing Airway Surgery: An Observational Prospective Cohort Study.气道手术患儿围手术期呼吸不良事件风险列线图模型的开发与验证:一项观察性前瞻性队列研究
Risk Manag Healthc Policy. 2022 Jan 6;15:1-12. doi: 10.2147/RMHP.S347401. eCollection 2022.
3
Development and Validation of Nomogram Prediction Model for Postoperative Sleep Disturbance in Patients Undergoing Non-Cardiac Surgery: A Prospective Cohort Study.

本文引用的文献

1
Survival Predictability Between the American Joint Committee on Cancer 8th Edition Staging System and the Barcelona Clinic Liver Cancer Classification in Patients with Hepatocellular Carcinoma.美国癌症联合委员会第 8 版分期系统与巴塞罗那临床肝癌分类在肝细胞癌患者中的生存预测性比较。
Oncologist. 2021 Mar;26(3):e445-e453. doi: 10.1002/onco.13535. Epub 2020 Oct 3.
2
Novel Prognostic Scores Based on Plasma Prothrombin Time and Fibrinogen Levels in Patients With AFP-Negative Hepatocellular Carcinoma.基于 AFP 阴性肝细胞癌患者血浆凝血酶原时间和纤维蛋白原水平的新型预后评分。
Cancer Control. 2020 Jan-Dec;27(1):1073274820915520. doi: 10.1177/1073274820915520.
3
非心脏手术患者术后睡眠障碍列线图预测模型的开发与验证:一项前瞻性队列研究
Nat Sci Sleep. 2021 Aug 24;13:1473-1483. doi: 10.2147/NSS.S319339. eCollection 2021.
Advances in resection and transplantation for hepatocellular carcinoma.
肝细胞癌切除和移植的进展。
J Hepatol. 2020 Feb;72(2):262-276. doi: 10.1016/j.jhep.2019.11.017.
4
A global view of hepatocellular carcinoma: trends, risk, prevention and management.全球视角下的肝细胞癌:趋势、风险、预防与管理。
Nat Rev Gastroenterol Hepatol. 2019 Oct;16(10):589-604. doi: 10.1038/s41575-019-0186-y. Epub 2019 Aug 22.
5
Prognosis After Resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B Hepatocellular Carcinoma: A Comprehensive Assessment of the Current BCLC Classification.巴塞罗那临床肝癌(BCLC)分期 0、A 和 B 期肝细胞癌切除后的预后:对当前 BCLC 分类的综合评估。
Ann Surg Oncol. 2019 Oct;26(11):3693-3700. doi: 10.1245/s10434-019-07580-9. Epub 2019 Jul 2.
6
A sample model established by S-index predicting overall survival after curative resection of primary hepatocellular carcinoma.通过S指数建立的预测原发性肝细胞癌根治性切除术后总生存期的样本模型。
Cancer Manag Res. 2019 Jan 14;11:693-703. doi: 10.2147/CMAR.S193593. eCollection 2019.
7
Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection.肝脏和脾脏硬度在预测肝癌切除术后复发中的作用。
J Hepatol. 2019 Mar;70(3):440-448. doi: 10.1016/j.jhep.2018.10.022. Epub 2018 Oct 31.
8
Extent of portal vein tumour thrombosis in patients with hepatocellular carcinoma: The more, the worse?肝细胞癌患者门静脉癌栓的范围:越多,越差?
Liver Int. 2019 Feb;39(2):324-331. doi: 10.1111/liv.13988. Epub 2018 Nov 9.
9
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
10
Occam's razor: from Ockham's to modern data science.奥卡姆剃刀原理:从奥卡姆到现代数据科学
Sci Prog. 2018 Sep 1;101(3):261-272. doi: 10.3184/003685018X15295002645082. Epub 2018 Jul 19.